From pilots to performance: why pharma's AI challenge is human, not technical
AI is now a strategic priority across the pharmaceutical industry, yet many organisations are struggling to turn investment into sustained results. This whitepaper explores why the challenge is increasingly human rather than technical, and what it takes to build the capability to realise AI's full potential.
Why AI success depends on people, not technology
While AI is now present across most organisations, only 9% describe adoption as high and sustained.
In this report:
- Why AI adoption is outpacing AI impact
- The human barriers holding organisations back
- How to shift from training programmes to performance
- Why persona-led capability models are gaining traction
- What effective AI capability-building looks like in practice